Your browser doesn't support javascript.
loading
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.
Xue, Chengyuan; Yu, Denise M T; Gherardi, Samuele; Koach, Jessica; Milazzo, Giorgio; Gamble, Laura; Liu, Bing; Valli, Emanuele; Russell, Amanda J; London, Wendy B; Liu, Tao; Cheung, Belamy B; Marshall, Glenn M; Perini, Giovanni; Haber, Michelle; Norris, Murray D.
Afiliación
  • Xue C; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Yu DM; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Gherardi S; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Koach J; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Milazzo G; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Gamble L; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Liu B; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Valli E; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Russell AJ; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • London WB; Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Liu T; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Cheung BB; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Marshall GM; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Perini G; Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia.
  • Haber M; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Norris MD; CIRI Health Sciences and Technologies University of Bologna, Bologna, Italy.
Oncotarget ; 7(34): 54937-54951, 2016 Aug 23.
Article en En | MEDLINE | ID: mdl-27448979
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Regulación Neoplásica de la Expresión Génica / Proteínas de Unión al ADN / Proteína Proto-Oncogénica N-Myc / Neuroblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Regulación Neoplásica de la Expresión Génica / Proteínas de Unión al ADN / Proteína Proto-Oncogénica N-Myc / Neuroblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos